Get startedLog in
    Picture of Soleno Therapeutics logo

    SLNO — Soleno Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    All News

    Brief: Soleno Therapeutics Says Death Of Patient Not Related To VYKAT XR Treatment

    Picture of Soleno Therapeutics logoSoleno Therapeutics
    10/09/2025 19:40
    Sept 10 (Reuters) - Soleno Therapeutics Inc SLNO.O:

SOLENO THERAPEUTICS INC - AWARE OF SERIOUS ADVERSE EVENT IN FDA'S FAERS REGARDING PATIENT WHO DIED - SEC FILING

SOLENO THERAPEUTICS INC - CASE REPORTED AS NOT RELATED TO VYKAT XR TREATMENT - SEC FILING

SOLENO THERAPEUTICS INC - PATIENT WAS A 17-YEAR-OLD MALE WHO DIED FROM PULMONARY EMBOLUS - SEC FILING

SOLENO THERAPEUTICS INC - VYKAT XR HAS PROVEN SAFETY AND EFFICACY PROFILE - SEC FILING

Source text: [ID:n0001193125-25-199882]

Further company coverage: SLNO.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Soleno Therapeutics

    See all news